Insider Buying: Bioventix PLC (LON:BVXP) Insider Buys 11 Shares of Stock

Bioventix PLC (LON:BVXP - Get Free Report) insider Bruce Hiscock bought 11 shares of the company's stock in a transaction dated Monday, April 29th. The shares were acquired at an average price of GBX 4,552 ($57.18) per share, for a total transaction of £500.72 ($628.97).

Bioventix Price Performance

LON BVXP traded down GBX 175 ($2.20) during trading hours on Tuesday, reaching GBX 4,275 ($53.70). 11,226 shares of the company's stock traded hands, compared to its average volume of 5,713. The firm has a market cap of £223.16 million, a PE ratio of 2,622.70 and a beta of 0.36. Bioventix PLC has a 52-week low of GBX 3,402 ($42.73) and a 52-week high of GBX 5,100 ($64.06). The firm has a 50-day simple moving average of GBX 4,644.32 and a 200 day simple moving average of GBX 4,315.30.

Bioventix Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, April 11th were given a GBX 68 ($0.85) dividend. The ex-dividend date of this dividend was Thursday, April 11th. This represents a dividend yield of 1.48%. Bioventix's dividend payout ratio is currently 9,693.25%.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.